SOW
FATE icon

State of Wyoming’s Fate Therapeutics FATE Stock Holding History

State of Wyoming’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-94,501
Closed -$353K – 1676
2023
Q4 		$353K Buy
94,501
+80,242
+563% +$189K 0.07% 234
2023
Q3 		$30.2K Buy
+14,259
New +$47.2K 0.01% 1413
2022
Q2 		– Sell
-5,012
Closed -$194K – 1948
2022
Q1 		$194K Buy
5,012
+1,699
+51% +$65.8K 0.1% 211
2021
Q4 		$194K Buy
3,313
+657
+25% +$37.2K 0.09% 232
2021
Q3 		$157K Sell
2,656
-1,548
-37% -$121K 0.1% 244
2021
Q2 		$365K Buy
4,204
+2,613
+164% +$211K 0.23% 65
2021
Q1 		$131K Buy
+1,591
New +$152K 0.21% 84

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State of Wyoming's FATE Position: Q1 2024 in Review

State of Wyoming sold out of Fate Therapeutics (FATE) in Q1 2024, closing a stake of 94,501 shares — an estimated $353K sold.

State of Wyoming first reported a position in FATE in Q1 2021 and held it in 7 quarters. The position peaked at $365K in Q2 2021. 167 funds tracked by Wall St. Rank hold FATE as of Q1 2024.

  • State of Wyoming reported no remaining Fate Therapeutics position as of Q1 2024 after selling out during the quarter.
  • State of Wyoming sold 94,501 Fate Therapeutics shares in Q1 2024, an estimated $353K.
  • State of Wyoming first reported a position in Fate Therapeutics in Q1 2021 and held it in 7 quarters.
  • State of Wyoming's Fate Therapeutics position peaked at $365K in Q2 2021.
  • 167 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2024.

Based on State of Wyoming's 13F filing for Q1 2024, filed 14 May 2024.